article · Kidney International Reports
levels.CT scan revealed multiple lung and liver nodules, suggestive of disease recurrence.Instead, liver biopsy confirmed small cell lung cancer, for which chemotherapy/immunotherapy was initiated.Results: Nine months later, she presented with severe hypokalemia (2.3 mmol/L) and alkalosis (CO2 38 mmol/L) but was normonatremic (141) despite not taking her salt tablets.Urine studies revealed renal potassium wasting, and serum studies showed elevated AM cortisol (49.1 mcg/dL) and high ACTH (181 pg/mL).CT scan showed bilateral adrenal thickening.A high-dose dexamethasone suppression test confirmed ectopic Cushing syndrome, so she was started on metyrapone.Within 48 hours, her [sodium] declined from 138 to 130 mmol/L.Copeptin later came back at >5,000 pmol/L.Tolvaptan was considered, but fluid restriction, salt tablets, and urea normalized her [sodium].Conclusion: Hyponatremia resolving to hypokalemia/alkalosis and recurring to hyponatremia again should raise the suspicion for dual paraneoplastic syndrome in SCLC.Our patient exhibited a triphasic electrolyte evolution, highlighting an intricate hormonal interplay: hyponatremia due to SIADH, normalization during hypercortisolism, and recurrent hyponatremia after cortisol reduction.The high cortisol's mineralocorticoid activity, overwhelming 11beta-hydroxysteroid dehydrogenase, likely masked hyponatremia, and then metyraponeinduced cortisol suppression may have unmasked a persistent ADHdriven water retention.Anticipating this triphasic course is key to the diagnosis and treatment of a rare dual paraneoplastic syndrome in SCLC.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/j.ekir.2026.105969
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.